Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP47842.RA9ph_-7xJ2Irx8sOj_cUbic1iya2GX-v9vQHTLLb-nT0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP47842.RA9ph_-7xJ2Irx8sOj_cUbic1iya2GX-v9vQHTLLb-nT0130_assertion type Assertion NP47842.RA9ph_-7xJ2Irx8sOj_cUbic1iya2GX-v9vQHTLLb-nT0130_head.
- NP47842.RA9ph_-7xJ2Irx8sOj_cUbic1iya2GX-v9vQHTLLb-nT0130_assertion description "[B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP47842.RA9ph_-7xJ2Irx8sOj_cUbic1iya2GX-v9vQHTLLb-nT0130_provenance.
- NP47842.RA9ph_-7xJ2Irx8sOj_cUbic1iya2GX-v9vQHTLLb-nT0130_assertion evidence source_evidence_literature NP47842.RA9ph_-7xJ2Irx8sOj_cUbic1iya2GX-v9vQHTLLb-nT0130_provenance.
- NP47842.RA9ph_-7xJ2Irx8sOj_cUbic1iya2GX-v9vQHTLLb-nT0130_assertion SIO_000772 12640257 NP47842.RA9ph_-7xJ2Irx8sOj_cUbic1iya2GX-v9vQHTLLb-nT0130_provenance.
- NP47842.RA9ph_-7xJ2Irx8sOj_cUbic1iya2GX-v9vQHTLLb-nT0130_assertion wasDerivedFrom gad-20130706 NP47842.RA9ph_-7xJ2Irx8sOj_cUbic1iya2GX-v9vQHTLLb-nT0130_provenance.
- NP47842.RA9ph_-7xJ2Irx8sOj_cUbic1iya2GX-v9vQHTLLb-nT0130_assertion wasGeneratedBy ECO_0000203 NP47842.RA9ph_-7xJ2Irx8sOj_cUbic1iya2GX-v9vQHTLLb-nT0130_provenance.